May is Melanoma Awareness Month
…and thrive. Despite melanoma. Regardless of melanoma. Beyond melanoma. We worked in conjunction with our international advocates on this campaign,…
May is Melanoma Awareness Month
…and thrive. Despite melanoma. Regardless of melanoma. Beyond melanoma. We worked in conjunction with our international advocates on this campaign,…
Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute
…How would a collaborative melanoma tissue bank consortium help advance the prevention, detection, and treatment of melanoma? A collaborative melanoma tissue…
,
Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma
…safety. About Melanoma Melanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located…
,
,
Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma
…plans that incorporate DecisionDx-Melanoma test results. Through June 30, 2021, DecisionDx-Melanoma has been ordered 78,277 times for use in patients…
,
,
World Health Organization Predicts Half a Million With Melanoma in 2040
Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…
In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
,
In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology
…great potential in combination with nivolumab and to be most effective as the first treatment of metastatic melanoma. This study…
,
AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center
…for melanoma while improving the lives of those it affects. AIM’s global research initiatives include The International Melanoma Tissue Bank…
,
,
Spinning For Melanoma
…accelerate the quest for the cure. Val’s drive came from her daughter Charlie’s death from melanoma at 26 years old.…
,
,
In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
…forms of immunotherapy. Additionally, because melanoma is so resistant to chemotherapy and radiation, the relative benefits of immunotherapy are greater…
,
,
Recent Posts
Aug. 07, 2026
RP1 Approved: A Long Road to a New Option for Patients
Aug. 07, 2026
Patient Webinar: Understanding Your Second-Line Options
Aug. 06, 2026
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
Aug. 06, 2026
AIM at Melanoma President Samantha Guild Receives SITC’s 2026 Tara Withington Public Service Award
Aug. 03, 2026